Zobrazeno 1 - 10 of 937 pro vyhledávání: '"Lupo, B"'
1
Akademický článek
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients.
Autor: Leto SM; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Grassi E; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Avolio M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Vurchio V; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Cottino F; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Ferri M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Zanella ER; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Borgato S; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Corti G; Department of Oncology, University of Torino, Candiolo, Torino, Italy., di Blasio L; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Somale D; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Aptuit, an Evotec Company, Verona, Italy., Vara-Messler M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy.; Sanofi Belgium, Zwijnaarde, Belgium., Galimi F; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Sassi F; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Lupo B; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Catalano I; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Pinnelli M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Viviani M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Sperti L; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Mellano A; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Ferrero A; Mauriziano Umberto I Hospital, Torino, Italy., Zingaretti CC; Mauriziano Umberto I Hospital, Torino, Italy., Puliafito A; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Primo L; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Bertotti A; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy. andrea.bertotti@ircc.it.; Department of Oncology, University of Torino, Candiolo, Torino, Italy. andrea.bertotti@ircc.it., Trusolino L; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy. livio.trusolino@ircc.it.; Department of Oncology, University of Torino, Candiolo, Torino, Italy. livio.trusolino@ircc.it.
Publikováno v: Nature communications [Nat Commun] 2024 Aug 29; Vol. 15 (1), pp. 7495. Date of Electronic Publication: 2024 Aug 29.
Zobrazit plný text záznamu
2
Akademický článek
Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer.
Autor: Piastra V; Translational Oncology Research Unit, Department of Diagnostic Research and Technological Innovation, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi, Rome, 53 - 00144, Italy.; Department of Science, University Roma Tre, Rome, Italy., Ganci F; Translational Oncology Research Unit, Department of Diagnostic Research and Technological Innovation, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi, Rome, 53 - 00144, Italy., Sacconi A; Translational Oncology Research Unit, Department of Diagnostic Research and Technological Innovation, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi, Rome, 53 - 00144, Italy., Pranteda A; Translational Oncology Research Unit, Department of Diagnostic Research and Technological Innovation, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi, Rome, 53 - 00144, Italy.; Department of Science, University Roma Tre, Rome, Italy., Allegretti M; Translational Oncology Research Unit, Department of Diagnostic Research and Technological Innovation, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi, Rome, 53 - 00144, Italy., Bernardini R; Interdepartmental Center for Comparative Medicine, Alternative Techniques and Aquaculture (CIMETA), University of Rome Tor Vergata, Rome, Italy., Serra M; Translational Oncology Research Unit, Department of Diagnostic Research and Technological Innovation, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi, Rome, 53 - 00144, Italy.; Interdepartmental Center for Comparative Medicine, Alternative Techniques and Aquaculture (CIMETA), University of Rome Tor Vergata, Rome, Italy., Lupo B; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Turin, Italy.; Department of Oncology, University of Torino, Candiolo, Turin, Italy., Dell'Aquila E; Second Division of Medical Oncology, IRCCS - Regina Elena National Cancer Institute, Rome, Italy., Ferretti G; First Division of Medical Oncology, IRCCS - Regina Elena National Cancer Institute, Rome, Italy., Pescarmona E; Department of Pathology, IRCCS - Regina Elena National Cancer Institute, Rome, Italy., Bartolazzi A; Pathology Research Laboratory, St Andrea University Hospital, Rome, Italy., Blandino G; Translational Oncology Research Unit, Department of Diagnostic Research and Technological Innovation, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi, Rome, 53 - 00144, Italy., Trusolino L; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Turin, Italy.; Department of Oncology, University of Torino, Candiolo, Turin, Italy., Bossi G; Translational Oncology Research Unit, Department of Diagnostic Research and Technological Innovation, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi, Rome, 53 - 00144, Italy. gianluca.bossi@ifo.it.
Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Aug 20; Vol. 43 (1), pp. 234. Date of Electronic Publication: 2024 Aug 20.
Zobrazit plný text záznamu
3
Akademický článek
Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity.
Autor: Cascianelli S; Department of Electronics, Information and Bioengineering, Politecnico Di Milano, Piazza Leonardo da Vinci 32, 20133, Milan, Italy., Barbera C; Department of Electronics, Information and Bioengineering, Politecnico Di Milano, Piazza Leonardo da Vinci 32, 20133, Milan, Italy., Ulla AA; Department of Oncology, University of Turin, S.P. 142, Km 3.95, 10060, Candiolo (TO), Turin, Italy., Grassi E; Department of Oncology, University of Turin, S.P. 142, Km 3.95, 10060, Candiolo (TO), Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, S.P. 142, Km 3.95, 10060, Candiolo (TO), Italy., Lupo B; Department of Oncology, University of Turin, S.P. 142, Km 3.95, 10060, Candiolo (TO), Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, S.P. 142, Km 3.95, 10060, Candiolo (TO), Italy., Pasini D; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.; Department of Health Sciences, University of Milan, Via A. Di Rudini 8, 20142, Milan, Italy., Bertotti A; Department of Oncology, University of Turin, S.P. 142, Km 3.95, 10060, Candiolo (TO), Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, S.P. 142, Km 3.95, 10060, Candiolo (TO), Italy., Trusolino L; Department of Oncology, University of Turin, S.P. 142, Km 3.95, 10060, Candiolo (TO), Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, S.P. 142, Km 3.95, 10060, Candiolo (TO), Italy., Medico E; Department of Oncology, University of Turin, S.P. 142, Km 3.95, 10060, Candiolo (TO), Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, S.P. 142, Km 3.95, 10060, Candiolo (TO), Italy., Isella C; Department of Oncology, University of Turin, S.P. 142, Km 3.95, 10060, Candiolo (TO), Turin, Italy. c.isella@unito.it.; Candiolo Cancer Institute, FPO-IRCCS, S.P. 142, Km 3.95, 10060, Candiolo (TO), Italy. c.isella@unito.it., Masseroli M; Department of Electronics, Information and Bioengineering, Politecnico Di Milano, Piazza Leonardo da Vinci 32, 20133, Milan, Italy. marco.masseroli@polimi.it.
Publikováno v: Genome medicine [Genome Med] 2023 May 15; Vol. 15 (1), pp. 37. Date of Electronic Publication: 2023 May 15.
Zobrazit plný text záznamu
4
Akademický článek
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer.
Autor: Beekhof R; Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands., Bertotti A; Candiolo Cancer Institute - FPO IRCCS, Candiolo, 10060 Torino, Italy.; Department of Oncology, University of Torino, Candiolo, 10060 Torino, Italy., Böttger F; Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Oncode Institute, 1066 CX Amsterdam, Netherlands., Vurchio V; Candiolo Cancer Institute - FPO IRCCS, Candiolo, 10060 Torino, Italy.; Department of Oncology, University of Torino, Candiolo, 10060 Torino, Italy., Cottino F; Candiolo Cancer Institute - FPO IRCCS, Candiolo, 10060 Torino, Italy., Zanella ER; Candiolo Cancer Institute - FPO IRCCS, Candiolo, 10060 Torino, Italy., Migliardi G; Candiolo Cancer Institute - FPO IRCCS, Candiolo, 10060 Torino, Italy.; Department of Oncology, University of Torino, Candiolo, 10060 Torino, Italy., Viviani M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, 10060 Torino, Italy.; Department of Oncology, University of Torino, Candiolo, 10060 Torino, Italy., Grassi E; Candiolo Cancer Institute - FPO IRCCS, Candiolo, 10060 Torino, Italy.; Department of Oncology, University of Torino, Candiolo, 10060 Torino, Italy., Lupo B; Candiolo Cancer Institute - FPO IRCCS, Candiolo, 10060 Torino, Italy., Henneman AA; Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands., Knol JC; Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands., Pham TV; Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands., de Goeij-de Haas R; Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands., Piersma SR; Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands., Labots M; Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands., Verheul HMW; Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, Netherlands., Trusolino L; Candiolo Cancer Institute - FPO IRCCS, Candiolo, 10060 Torino, Italy.; Department of Oncology, University of Torino, Candiolo, 10060 Torino, Italy., Jimenez CR; Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.
Publikováno v: Science translational medicine [Sci Transl Med] 2023 Aug 16; Vol. 15 (709), pp. eabm3687. Date of Electronic Publication: 2023 Aug 16.
Zobrazit plný text záznamu
6
Heart rate variability in patients with essential tremor: A cross sectional study
Autor: Maria Salsone a, Rita Nistico' a, Basilio Vescio a, Fabiana Novellino a, Maurizio Morelli b, Angela Lupo b, Gennarina Arabia b, Aldo Quattrone a, b
Publikováno v: Parkinsonism & related disorders 33 (2016): 134–137. doi:10.1016/j.parkreldis.2016.09.027
info:cnr-pdr/source/autori:Maria Salsone a, Rita Nistico' a, Basilio Vescio a, Fabiana Novellino a, Maurizio Morelli b, Angela Lupo b, Gennarina Arabia b, Aldo Quattrone a,b/titolo:Heart rate variability in patients with essential tremor: A cross sectional study./doi:10.1016%2Fj.parkreldis.2016.09.027/rivista:Parkinsonism & related disorders/anno:2016/pagina_da:134/pagina_a:137/intervallo_pagine:134–137/volume:33
Objective To investigate heart rate variability (HRV) in patients with Essential Tremor (ET) in comparison with patients with Parkinson's Disease (PD). Methods This is a cross sectional control study including 10 patients with ET, 10 patients with PD
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10aa92b91f80ef97e045e59f2d12153a
https://doi.org/10.1016/j.parkreldis.2016.09.027
Zobrazit plný text záznamu
8
Akademický článek
Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3.
Autor: Tringali, C.1, Lupo, B.1, Cirillo, F.1, Papini, N.1,2, Anastasia, L.1,2, Lamorte, G.3, Colombi, P.4, Bresciani, R.4, Monti, E.4, Tettamanti, G.2 guido.tettamanti@unimi.it, Venerando, B.1,2 bruno.venerando@unimi.it
Publikováno v: Cell Death & Differentiation. Jan2009, Vol. 16 Issue 1, p164-174. 11p. 2 Black and White Photographs, 1 Chart, 6 Graphs.
Zobrazit plný text záznamu
9
Akademický článek
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI.
Autor: Cao D; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Levin MA; Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sartori S; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Claessen B; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Roumeliotis A; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Zhang Z; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Nicolas J; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chandiramani R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Bedekar R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Waseem Z; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Goel R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chiarito M; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy, and Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy., Lupo B; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Jhang J; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Dangas GD; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Baber U; The University of Oklahoma Health Sciences Center, Oklahoma, OK, USA., Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA., Sharma SK; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kini AS; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. roxana.mehran@mountsinai.org.; Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY, 10029-6574, USA. roxana.mehran@mountsinai.org.
Publikováno v: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2022 Feb; Vol. 53 (2), pp. 380-389. Date of Electronic Publication: 2021 Aug 12.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje